Abstract
Antibiotic production is a complex capital intensive process, which divides naturally into two segments, fermentation and separation/purification. The separation and purification section is very large as a result of the number of processing steps required (up to 60) and the need to purify and recycle large quantities of organic solvents. Separation and purification is not generic within the antibiotic industry. Not only does each individual antibiotic require a different separation process, but also there are many different separation schemes in use for the same antibiotic. Much research is currently in progress on three relatively new separation techniques on a commercial level, which may lead to substantial reductions in the complexity of the process; chromatography (both conventional preparative HPLC and annular chromatography), supercritical extraction, and various membrane processes.
Similar content being viewed by others
References
Sollmann, T. (1957),A Manual of Pharmacology, 8th ed., W. B. Saunders, London.
Perlman, D. (1969),Adv. in Appl. Microb. 11, 159, Academic, New York.
Stinson, S. C. (1985),C & E News,16, 25.
Kertes, A. S. (1985),Solubility Data Series,16 & 17, Pergamon, NY.
Atkinson, B., and Mavituna, F. (1983),Biochem. Eng. and Biotechnol. Handbook, Nature Press, London.
{au{fnLepetit}, {gnS. P. A.}}Production of the Antibiotic Tetracycline by Fermentation, British Patent #775 139, May 22, 1957.
Minieri, P. P., and Sokol, H.Process for the Preparation of Tetracycline and Chlortetracycline, United States Patent # 2,734,018 February 7, 1956.
McGhee, W. J., and Megna, J. C.Process for the Production of Tetracycline, United States Patent #2,776,243 January 1, 1957.
Okabe, M., and Aiba, S. (1975),J. Ferment. Technol. 53(10), 730.
Elder, A. L., ed. (1970), AlChE Symp. Ser., 66, 1.
Hugo, W. B., and Russel, A. D. (1977),Pharm. Microb., Blackwell, London.
Inman, F. N. (1984),Filtr. Sep.,May/June, 165.
Peppier, H. J., and Perlman, D. (1979),Microb. Technol., 2nd ed., Academic, NY.
Niss, H. F.Process for the Manufacture of Cephalosporin C, United States Patent #3,539,694 June 23, 1967.
Wildfeuer, M. E. (1985),Pur. Ferment. Prod., 155.
Hockenhold, D. J. D. (1959),Fermentation of the Tetracyclines, Interscience, NY.
Plues, S.Antibiotic Purification Process, United States Patent #3,983,108 September 28, 1976.
Gavrilescu, M., Pal, C, User, S., Tonescu, S., and Margineanu, N.Process for the Isolation and Purification of Tetracycline, British Patent #1 368 668 October 2, 1974.
Kalyanpur, M., Seka, W., and Siwak, M. (1984),SA Filtr.,Nov., 8.
Cantwell, A. M., Calderone, R., and Sienko, M. (1984),J. Chrom.,316, 133.
Dwyer, J., Findeisen, C., and Seka, W. (1984),Pharm. Tech.,8(9), 100.
Dwyer, J. (1984),World Biotech. Rept., 651.
Knox, J. H., and Jurand, J. (1975),J. Chrom. 110, 103.
Yoshikawa, T. T., Maltra, S. K., Schotz, M. C., and Guze, L. B. (1980),Rev. Infec. Dis. 2(2), 169.
Watson, I. D., Platt, D. J., McIntosh, S. J., Stewart, M. J., and Cohen, H. N. (1982),Clinical Biol. Dev. HPLC, 180.
White, E. R., and Zarembo, J. E. (1981),J. Antib.,24(7), 836.
Kalyanpur, M., Seka, W., and Siwak, N. (1985),Dev. Ind. Micro. 26, 455.
Miller, R. D., and Neuss, N. (1976),J. Antib. 29(9), 902.
Mascone, C. F. (1987),Chem. Eng. 19, 21.
Stewart, G. T.Purified Cephalosporins and Their Production, British Patent #1232 656 May 23, 1968.
Blackburn, D. W.Cephalosporin Purification Process, United States Patent # 4,028,755 June 7, 1977.
Scott, C. D., Spence, R. D., and Sission, W. G. (1976),J. Chromatogr. 126, 381.
Begovich, J. M., and Sisson, W. G. (1984),AlChE J. 30, 705.
Larson, K. A., and King, M. L. (1986),Biotec. Prog.,2(2), 73.
Cohen, H.Isolation and Purification of Antibiotics, German Patent #33 18 194 May 19, 1983.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bienkowski, P.R., Lee, D.D. & Byers, C.H. Evaluation of separation and purification processes in the antibiotic industry. Appl Biochem Biotechnol 18, 261–273 (1988). https://doi.org/10.1007/BF02930830
Issue Date:
DOI: https://doi.org/10.1007/BF02930830